Stay updated on Venetoclax Combo vs Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Combo vs Azacitidine in AML Clinical Trial page.

Latest updates to the Venetoclax Combo vs Azacitidine in AML Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded a note that PubMed-derived publications are automatically populated and may not relate to the study, and updated the revision tag to v3.3.2.SummaryDifference0.0%

- Check17 days agoChange DetectedThe government funding status notice at the top of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedThe screenshots show only minor formatting changes with no alteration to core study details such as the title, NCT number, sponsor, enrollment, locations, eligibility criteria, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check60 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference1%

- Check67 days agoChange DetectedThe page now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a restructuring and possible narrowing of the domain coverage.SummaryDifference0.2%

- Check82 days agoChange DetectedAdded a Leukemia article citation and updated to revision v3.0.2; removed the 'Back to Top' link.SummaryDifference1%

Stay in the know with updates to Venetoclax Combo vs Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo vs Azacitidine in AML Clinical Trial page.